Lir Life Sciences (FRA:N790) Beginning Cash Position: €0.57 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:N790 Lir Life Sciences Corp FRA:N790
16 GF Score
Price €0.15
! 2 Warning Signs
View Full Analysis

What is Lir Life Sciences Beginning Cash Position?

Lir Life Sciences FRA:N790 +31.30% 16 Beginning Cash Position is €0.57 Mil as of Apr. 2026. GuruFocus rates FRA:N790 with a GF Score™ of 16/100. The stock has 2 warning signs investors should review.

Lir Life Sciences's Beginning Cash Position for the quarter that ended in Apr. 2026 was €0.57 Mil.

Lir Life Sciences's quarterly Beginning Cash Position declined from Oct. 2025 (€0.89 Mil) to Jan. 2026 (€0.69 Mil) and declined from Jan. 2026 (€0.69 Mil) to Apr. 2026 (€0.57 Mil).

Lir Life Sciences's annual Beginning Cash Position increased from Apr. 2024 (€0.00 Mil) to Apr. 2025 (€0.12 Mil) but then declined from Apr. 2025 (€0.12 Mil) to Apr. 2026 (€0.08 Mil).

Lir Life Sciences Beginning Cash Position Related Terms

Lir Life Sciences Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Lir Life Sciences's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lir Life Sciences Beginning Cash Position Chart

Lir Life Sciences Annual Data
Trend Apr24 Apr25 Apr26
Beginning Cash Position
0.00 0.12 0.08

Lir Life Sciences Quarterly Data
Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only 0.13 0.08 0.89 0.69 0.57
FRA:N790
16GF Score
Lir Life Sciences Corp FRA:N790
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lir Life Sciences Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of €0.57 Mil mean?
Lir Life Sciences (FRA:N790) has a Beginning Cash Position of €0.57 Mil as of Apr. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Lir Life Sciences and its competitors.
Is Lir Life Sciences' Beginning Cash Position too high?
Lir Life Sciences' current Beginning Cash Position is €0.57 Mil. Overall, Lir Life Sciences has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Lir Life Sciences' Beginning Cash Position compare to VRTX and REGN?
Lir Life Sciences' Beginning Cash Position of €0.57 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Lir Life Sciences and its competitors. Lir Life Sciences's current Beginning Cash Position is €0.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lir Life Sciences stock overvalued right now?
Lir Life Sciences (FRA:N790) has a current Beginning Cash Position of €0.57 Mil. The current Beginning Cash Position is €0.57 Mil. Lir Life Sciences' overall GF Score™ is 16/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Lir Life Sciences (FRA:N790), the current Beginning Cash Position is €0.57 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lir Life Sciences Business Description

Other Exchanges BBCMF:USASKNY:Canada
Address 505-1505 West 2nd Avenue, Vancouver, BC, CAN, V6J 1H2
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
16GF Score

Get the complete analysis for FRA:N790

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.15
Price